VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $215,136 | -43.0% | 7,145 | -38.8% | 0.00% | -60.0% |
| Q1 2023 | $377,492 | -60.4% | 11,669 | -64.9% | 0.01% | -84.8% |
| Q4 2022 | $954,063 | -3.6% | 33,289 | -18.9% | 0.03% | -15.4% |
| Q3 2022 | $990,000 | +13.3% | 41,033 | +28.5% | 0.04% | +11.4% |
| Q2 2022 | $874,000 | +47.4% | 31,938 | +106.7% | 0.04% | +66.7% |
| Q1 2022 | $593,000 | +109.5% | 15,453 | +74.7% | 0.02% | +133.3% |
| Q4 2021 | $283,000 | +204.3% | 8,843 | +249.7% | 0.01% | +80.0% |
| Q2 2020 | $93,000 | +52.5% | 2,529 | -3.7% | 0.01% | +25.0% |
| Q1 2020 | $61,000 | -99.0% | 2,627 | -98.8% | 0.00% | -99.2% |
| Q4 2019 | $6,175,000 | – | 210,902 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |